SAU:4007

Al Hammadi Holding Company · SAU · Healthcare · SAR · FY for 2024

Figures on this page computed 2026-11-08 12:42 UTC

Last close

n/aSAR

Market data

  • 10.2xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • computed
    • Computed from the filing for 2024
  • 17.3%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • Computed from the filing for 2024
    • Computed from the filing for 2024
    • Computed from the filing for 2024
    • Computed from the filing for 2024
    • Computed from the filing for 2024
    • Computed from the filing for 2024
  • 29.4%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • Computed from the filing for 2024
    • Computed from the filing for 2024
  • 21.7%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • Computed from the filing for 2024
    • Computed from the filing for 2024
  • 0.16Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • Computed from the filing for 2024
    • Computed from the filing for 2024
  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • computed

Five bars, one line

lens 7 of 9
1.28x
2.08x
2.03x
0.79x
n/a
SalesProfitFree cash flowDebtPrice
Each bar against this company's own average; the line is that average.
Computed2024
Computed2024
Computed2024
Computed2024
Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2024

  • Sales1.28x

    Its own average over 10 years, 901.6M.

  • Profit2.08x

    Its own average over 10 years, 162.7M.

  • Free cash flow2.03x

    Its own average over 10 years, 123.4M.

  • Debt0.79x

    Its own average over 10 years, 386.5M.

  • Pricen/a

    Its own average over 0 years. Market data

Profit is furthest from its own average, at 2.08 times.

Sales is 1.28 times its own 10-year average; Profit is 2.08 times its own 10-year average; Free cash flow is 2.03 times its own 10-year average; Debt is 0.79 times its own 10-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2024

  • Sales against its own 10-year average1.28
    Source
    computed
    Statement
    income
    Fiscal year
    2024
    Reported in
    SAR
  • Profit against its own 10-year average2.08
    Source
    computed
    Statement
    income
    Fiscal year
    2024
    Reported in
    SAR
  • Free cash flow against its own 10-year average2.03
    Source
    computed
    Statement
    income
    Fiscal year
    2024
    Reported in
    SAR
  • Debt against its own 10-year average0.79
    Source
    computed
    Statement
    income
    Fiscal year
    2024
    Reported in
    SAR
  • Price against its own 0-year averagen/aMarket data

    Not held.

    Source
    market
    Reported in
    SAR

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.